BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29987693)

  • 1. Effects of rTMS on Hippocampal Endocannabinoids and Depressive-like Behaviors in Adolescent Rats.
    Fang G; Wang Y
    Neurochem Res; 2018 Sep; 43(9):1756-1765. PubMed ID: 29987693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: the role of the endocannabinoid system.
    Wang HN; Wang L; Zhang RG; Chen YC; Liu L; Gao F; Nie H; Hou WG; Peng ZW; Tan Q
    J Psychiatr Res; 2014 Apr; 51():79-87. PubMed ID: 24479995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repetitive high-frequency transcranial magnetic stimulation reverses depressive-like behaviors and protein expression at hippocampal synapses in chronic unpredictable stress-treated rats by enhancing endocannabinoid signaling.
    Xue SS; Xue F; Ma QR; Wang SQ; Wang Y; Tan QR; Wang HN; Zhou CH; Peng ZW
    Pharmacol Biochem Behav; 2019 Sep; 184():172738. PubMed ID: 31229467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sevoflurane prevents stroke-induced depressive and anxiety behaviors by promoting cannabinoid receptor subtype I-dependent interaction between β-arrestin 2 and extracellular signal-regulated kinases 1/2 in the rat hippocampus.
    Zhang H; Li L; Sun Y; Zhang X; Zhang Y; Xu S; Zhao P; Liu T
    J Neurochem; 2016 May; 137(4):618-29. PubMed ID: 26991409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. rTMS ameliorated depressive-like behaviors by restoring HPA axis balance and prohibiting hippocampal neuron apoptosis in a rat model of depression.
    Zhao L; Ren H; Gu S; Li X; Jiang C; Li J; Zhang M; Mu J; Li W; Wang W; Zhang Z; Song J
    Psychiatry Res; 2018 Nov; 269():126-133. PubMed ID: 30145293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses.
    Wang Y; Gu N; Duan T; Kesner P; Blaskovits F; Liu J; Lu Y; Tong L; Gao F; Harris C; Mackie K; Li J; Tan Q; Hill MN; Yuan Z; Zhang X
    Mol Psychiatry; 2017 Feb; 22(2):215-226. PubMed ID: 27001616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect.
    McLaughlin RJ; Hill MN; Morrish AC; Gorzalka BB
    Behav Pharmacol; 2007 Sep; 18(5-6):431-8. PubMed ID: 17762511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of endocannabinoids in rapid suppression of stress responses by glucocorticoids in neonates.
    Buwembo A; Long H; Walker CD
    Neuroscience; 2013 Sep; 249():154-61. PubMed ID: 23131711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
    Imperatore R; Morello G; Luongo L; Taschler U; Romano R; De Gregorio D; Belardo C; Maione S; Di Marzo V; Cristino L
    J Neurochem; 2015 Nov; 135(4):799-813. PubMed ID: 26223500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-frequency repetitive transcranial magnetic stimulation improves depressive-like behaviors in CUMS-induced rats by modulating astrocyte GLT-1 to reduce glutamate toxicity.
    Wang X; Zhang F; Niu L; Yan J; Liu H; Wang D; Hui J; Dai H; Song J; Zhang Z
    J Affect Disord; 2024 Mar; 348():265-274. PubMed ID: 38159655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
    Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
    Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic repetitive transcranial magnetic stimulation enhances GABAergic and cholinergic metabolism in chronic unpredictable mild stress rat model: ¹H-NMR spectroscopy study at 11.7T.
    Kim SY; Lee DW; -Kim H; Bang E; Chae JH; Choe BY
    Neurosci Lett; 2014 Jun; 572():32-7. PubMed ID: 24796814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-frequency repetitive transcranial magnetic stimulation mitigates depression-like behaviors in CUMS-induced rats via FGF2/FGFR1/p-ERK signaling pathway.
    Yan J; Zhang F; Niu L; Wang X; Lu X; Ma C; Zhang C; Song J; Zhang Z
    Brain Res Bull; 2022 Jun; 183():94-103. PubMed ID: 35247488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors.
    de Morais H; de Souza CP; da Silva LM; Ferreira DM; Baggio CH; Vanvossen AC; Cristina de Carvalho M; da Silva-Santos JE; Bertoglio LJ; Cunha JM; Zanoveli JM
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1590-600. PubMed ID: 27544303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-frequency repetitive transcranial magnetic stimulation regulates neural oscillations of the hippocampus and prefrontal cortex in mice by modulating endocannabinoid signalling.
    Peng ZW; Zhou CH; Xue SS; Yu H; Shi QQ; Xue F; Chen YH; Tan QR; Wang HN
    J Affect Disord; 2023 Jun; 331():217-228. PubMed ID: 36965621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repetitive transcranial magnetic stimulation protects hippocampal plasticity in an animal model of depression.
    Kim EJ; Kim WR; Chi SE; Lee KH; Park EH; Chae JH; Park SK; Kim HT; Choi JS
    Neurosci Lett; 2006 Sep; 405(1-2):79-83. PubMed ID: 16839687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary intake of polyunsaturated fatty acids alleviates cognition deficits and depression-like behaviour via cannabinoid system in sleep deprivation rats.
    Wang T; Niu K; Fan A; Bi N; Tao H; Chen XT; Wang HL
    Behav Brain Res; 2020 Apr; 384():112545. PubMed ID: 32035867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quetiapine and repetitive transcranial magnetic stimulation ameliorate depression-like behaviors and up-regulate the proliferation of hippocampal-derived neural stem cells in a rat model of depression: The involvement of the BDNF/ERK signal pathway.
    Chen YH; Zhang RG; Xue F; Wang HN; Chen YC; Hu GT; Peng Y; Peng ZW; Tan QR
    Pharmacol Biochem Behav; 2015 Sep; 136():39-46. PubMed ID: 26176197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CB1 receptor antagonism increases hippocampal acetylcholine release: site and mechanism of action.
    Degroot A; Köfalvi A; Wade MR; Davis RJ; Rodrigues RJ; Rebola N; Cunha RA; Nomikos GG
    Mol Pharmacol; 2006 Oct; 70(4):1236-45. PubMed ID: 16855179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.
    Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.